Literature DB >> 3910302

Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose.

R O'Carroll, C Shapiro, J Bancroft.   

Abstract

The behavioural effects of varying the replacement dose of the oral androgen testosterone undecanoate (TU, Restandol) were investigated in eight hypogonadal men. Each man was withdrawn from his previous androgen replacement regimen and after a period of no treatment was administered four doses of TU (40, 80, 120 and 160 mg/d) in four successive one-month treatment periods using a double-blind design. Throughout the study each man recorded his sexual interest, behaviour and mood state using a daily diary form. In addition, four hypogonadal subjects had sleep erections and sleep quality assessed in the laboratory during a state of androgen withdrawal and again after a minimum of 5 months of androgen treatment. A dose response relationship was demonstrated for frequency of sexual thoughts, arousal accompanying sexual thoughts and well-being. Sleep erections improved significantly during testosterone administration. In men, sexual interest and sleep erections are androgen-dependent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3910302     DOI: 10.1111/j.1365-2265.1985.tb01113.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  14 in total

Review 1.  Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review.

Authors:  M S Bahrke; C E Yesalis; J E Wright
Journal:  Sports Med       Date:  1990-11       Impact factor: 11.136

2.  Treatment of depression in HIV+men: Literature review and report of an ongoing study of testosterone replacement therapy.

Authors:  J G Rabkin; G Wagner; R Rabkin
Journal:  Ann Behav Med       Date:  1996-03

Review 3.  Testosterone therapy in men: clinical and pharmacological perspectives.

Authors:  A Gambineri; R Pasquali
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

4.  Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.

Authors:  L Tax
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jul-Sep       Impact factor: 2.441

5.  Testosterone for erectile failure.

Authors:  T Mulligan; B Schmitt
Journal:  J Gen Intern Med       Date:  1993-09       Impact factor: 5.128

Review 6.  Women's sexuality: behaviors, responses, and individual differences.

Authors:  B L Andersen; J M Cyranowski
Journal:  J Consult Clin Psychol       Date:  1995-12

7.  Hormones and nocturnal penile tumescence in healthy aging men.

Authors:  R C Schiavi; D White; J Mandeli; P Schreiner-Engel
Journal:  Arch Sex Behav       Date:  1993-06

8.  Evaluating the effects of an alpha-2 adrenoceptor antagonist on erectile function in the human male. 1. The erectile response to erotic stimuli in volunteers.

Authors:  M Munoz; J Bancroft; M Turner
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

Review 9.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

10.  Pharmacologically induced hypogonadism and sexual function in healthy young women and men.

Authors:  Peter J Schmidt; Emma M Steinberg; Paula Palladino Negro; Nazli Haq; Carolyn Gibson; David R Rubinow
Journal:  Neuropsychopharmacology       Date:  2008-03-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.